Translational Research Office (TRO)


UCL academic delegation’s visit to the healthcare enterprises in Germany

28 April 2023

UCL academic delegation’s visit to the healthcare enterprises in Germany

Earlier this month, TRO’s Senior Business and Innovation Manager Dr David Collier led a UCL academic delegation visit to healthcare enterprises near Dusseldorf, Germany to:

  • exchange knowledge and ideas on life sciences and biomedical research
  • build on existing relationships and Germany-UK collaborations in science and innovation
  • forge new partnerships with industry in Germany

We cannot wait to continue building on these strategic links and support the growth of industry-academia partnerships along the translational pathway!
In the photo:
We thank 
QIAGEN for receiving the UCL delegation. 
Back row left to right - Thorsten Singer (QIAGEN); Daniel Wetterskog (UCL); Abhishek Sharma (QIAGEN); Martin Schlumpberger (QIAGEN); Siggi Hauch (QIAGEN)
Front row left to right - Stefan Guldin (UCL); Gert Attard (UCL); David Collier (UCL); Pascale Guillot (UCL); Constanze Kindler (QIAGEN)

Interested to stay informed of upcoming news, events and funding calls?

  • Subscribe to our newsletter and you would automatically become a member of UCL TINs (Therapeutic Innovation Networks) and be the first to receive our event invitations
  • Follow us on social media (LinkedInTwitter) and stay tuned to our news and updates.


  • TRO has created an online, internal portal (UCL sign-in required) to showcase the breadth of biomedical expertise at UCL and our partner hospitals, aiming to facilitate multidisciplinary collaborations and capabilities mapping. 

  • Input your profile to get your capabilities visible across UCL experts and potentially external partners facilitated by TRO, leading to collaboration and funding opportunities.